Carcinoma in situ of penis
ICD-10 D07.4 is a billable code used to indicate a diagnosis of carcinoma in situ of penis.
Carcinoma in situ of the penis is a localized form of cancer characterized by the presence of abnormal cells that have not invaded surrounding tissues. This condition is often associated with risk factors such as human papillomavirus (HPV) infection, poor hygiene, and phimosis. Clinically, it may present as a lesion or ulcer on the glans or shaft of the penis, which can be asymptomatic or cause discomfort. Diagnosis typically involves a biopsy to confirm the presence of atypical squamous cells. Surveillance protocols for patients diagnosed with carcinoma in situ include regular follow-up examinations and monitoring for any signs of progression to invasive cancer. The risk of progression varies, but studies suggest that untreated carcinoma in situ can lead to invasive squamous cell carcinoma in a significant number of cases. Therefore, timely intervention and management are crucial to prevent disease advancement.
Detailed clinical notes including biopsy results, treatment plans, and follow-up care.
Diagnosis and management of penile lesions, follow-up after biopsy, and treatment planning.
Urologists must ensure clear documentation of the lesion's characteristics and any associated symptoms.
Comprehensive skin examination notes, including descriptions of lesions and biopsy findings.
Evaluation of skin lesions on the penis, management of HPV-related conditions.
Dermatologists should document the appearance and location of lesions thoroughly to support coding.
Used when performing a biopsy to confirm carcinoma in situ.
Document the site of biopsy, method used, and results.
Urologists and dermatologists should ensure clear documentation of the biopsy process.
Carcinoma in situ is a precursor to invasive cancer, and early detection and management are crucial to prevent progression.
